Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report

doi:10.5306/wjco.v11.i7.504

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5753)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

336

WORD

116

HTML

2672

Figures (1-4)

320

Sum=3444

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

749

Download

1560

Sum=2309

Jul 24, 2020 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Jul 24, 2020; 11(7): 504-509
Published online Jul 24, 2020. doi: 10.5306/wjco.v11.i7.504

Full Size Figure Download Figure

Figure 4 Chest computed tomography showing the right pneumothorax. The cavity wall ruptured into the pleura (arrow).

Citation: Ozaki Y, Yoshimura A, Sawaki M, Hattori M, Gondo N, Kotani H, Adachi Y, Kataoka A, Sugino K, Horisawa N, Endo Y, Nozawa K, Sakamoto S, Iwata H. Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report. World J Clin Oncol 2020; 11(7): 504-509
URL: https://www.wjgnet.com/2218-4333/full/v11/i7/504.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i7.504